Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-10

FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion submitted by Zydus Pharmaceuticals USA Inc. The approval indicates changes to the product's labeling or fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

SUPPL AP for BUPROPION (BUPROPION)